Role of endocannabinoids in 5-HT2 receptor-mediated effects

Journal of Neurophysiology

Volumn 101, Issue 1, 2009, Pages 5-7

  Connelly, William M ^a,c   Baggott, Matthew J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOCANNABINOID; SEROTONIN 2 RECEPTOR;

DEPOLARIZATION; DRUG TARGETING; HUMAN; MENTAL DISEASE; NONHUMAN; OLIVARY NUCLEUS; PAIN; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SHORT SURVEY;

ANIMALS; BRAIN CHEMISTRY; CEREBELLUM; ELECTRIC STIMULATION; ENDOCANNABINOIDS; GLUTAMIC ACID; HUMANS; NERVE FIBERS; NEUROTRANSMITTER AGENTS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, SEROTONIN, 5-HT2; SIGNAL TRANSDUCTION;

EID: 58849141735     PISSN: 00223077     EISSN: 15221598     Source Type: Journal    
DOI: 10.1152/jn.91054.2008     Document Type: Short Survey

References (12)

1. Best AR, Regehr WG. Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J Neurosci 28: 6508-6515, 2008.
2. Chevaleyre V, Takahashi KA, Castillo PE. Endocannabinoid-mediated synaptic plasticity in the CNS. Annu Rev Neurosci 29: 37-76, 2006.
3. Gorzalka BB, Hill MN, Sun JC. Functional role of the endocannabinoid system and AMPA/kainate receptors in 5-HT2A receptor-mediated wet dog shakes. Eur J Pharmacol 516: 28-33, 2005.
4. 2+-assisted receptor-driven endocannabinoid release: mechanisms that associate presynaptic and postsynaptic activities. Curr Opin Neurobiol 17: 360-365, 2007.
5. Hohmann AG, Suplita RL, Bolton NM, Neely MH, Fegley D, Mangieri R, Krey JF, Walker JM, Holmes PV, Crystal JD, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. An endocannabinoid mechanism for stress-induced analgesia. Nature 435: 1108-1112, 2005.
6. Honda M, Uchida K, Tanabe M, Ono H. Fluvoxamine, a selective serotonin reuptake inhibitor, exerts its antiallodynic effects on neuropathic pain in mice via 5-HT2A/2C receptors. Neuropharmacology 51: 866-872, 2006.
7. Leung CG, Mason P. Effects of isoflurane concentration on the activity of ontomedullary raphe and medial reticular neurons in the rat. Brain Res 699: 71-82, 1995.
8. Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D, Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S. Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system. Eur J Neurosci 24: 2011-2020, 2006.
9. Parrish JC, Nichols DE. Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. J Neurochem 99: 1164-1175, 2006.
10. Roser P, Vollenweider FX, Kawohl W. Potential antipsychotic properties of central cannabinoid (CB(1)) receptor antagonists. World J Biol Psychiatry 7: 1-12, 2008.
11. Tokuyama S, Takahashi M, Kaneto H. Involvement of serotonergic receptor subtypes in the production of antinociception by psychological stress in mice. Jpn J Pharmacol 61: 237-234, 1993.
12. Walker JM, Hohmann AG. Cannabinoid mechanisms of pain suppression. Handb Exp Pharmacol 168: 509-554, 2005.